In this work, we utilized a strategy that belongs to the first group: using EVs for the transport of a potent neurotrophic factor, GDNF, and we have provided proof-of-concept in a transgenic mouse PD model, Parkin-Q311X(A) mice. Here, PRKN is linked to Parkinson disease.